Immuno Lec 9 - Immunoregulation Flashcards
the importance of regulating the immune system
-excessive response= allergies, autoimmunity, and lymphoid tumors can occur
-defective response = increased infections (bc not responding against robust pathogen), increased cancers (as you age the immune system decreases, which is why most cancer is diagnose in the older population
evidence of immunological tolerance
- Fusion of the placentas of
dizygotic twin calves results in
the development of calf chimeras - Hematopoietic stem cells from
each animal colonize the bone
marrow of the other - Each chimera is tolerant to its
twin’s cells and will accept a skin
graft from its twin despite the
genetic differences
T cells are rendered tolerant of self antigens
-Failure to do so risks autoimmune disease
There are two mechanisms to induce T cell tolerance:
* Central tolerance
- Strongly self‐reactive T cells (TCRs that bind self‐derived peptides with high affinity) are killed during thymic
development - Peripheral tolerance
- Weakly self‐reactive T cells (TCRs that bind self‐derived peptides with low affinity) are “turned off”
- These can be activated to kill cancerous/dangerous self
- Note: this means that a natural T cell response against cancerous cells is relatively weak
central T cell tolerance
- How the thymus induces central T cell tolerance by negative selection
- Most surviving T cells are unreactive to autoantigens but can respond to foreign antigenic peptides in association with MHC molecules because of positive selection
peripheral T cell tolerance
Peripheral tolerance through clonal anergy will develop if a TCR is stimulated by an epitope in the absence of simultaneous co‐ stimulation through the CD28/CD80 or CD28/CD86 pathway.
regulating T cells at the immunological synapse
-The major “accessory” molecules of T cells, so called because they participate in responses to antigens but are not the receptors for antigen. Cytotoxic T Lymphocyte Antigen‐4 (CTLA‐4; aka CD152) is a receptor for B7 molecules that delivers inhibitory signals and has a role in shutting off T cell responses. VLA molecules are integrins involved in leukocyte binding to endothelium. APC, antigen‐presenting cell; ICAM‐1, intercellular adhesion molecule‐1; LFA‐1, leukocyte function– associated antigen‐1; MHC, major histocompatibility complex; TCR, T cell receptor; VLA, very late antigen
regulating T cells at the immunological synapse; practical application
- To treat cancers
- Tumour‐infiltrating T cells become highly activated due to the presence of excessive target antigens so they up‐regulate CTLA‐4, which causes them to get shut down prematurely
- An antibody to block signaling through CTLA‐4 can prevent this
- Such an antibody is called an “immunological checkpoint inhibitor”
- This prolongs T cell activation and, therefore, killing of cancer cells
regulatory T cells (Tregs, CD4+CD25Foxp3+)
- The production and functions of regulatory T cells
- They are generated by the combined actions of IL‐2 and TGF‐β as well as the presence of retinoic acid
- They characteristically produce the suppressive cytokines TGF‐β, IL‐10, and IL‐35
T helper-17 (Th17) cells
-The generation of Th1 and Th17 cells depends upon the production of IL‐12 or IL‐23 by antigen‐presenting cells. Th1 cells promote cell‐mediated responses, Th17 cells promote innate responses via secretion of interleukin‐17 (IL‐17)
B cell tolerance
- B cells are harder to tolerize than T cells (this is why most autoimmune diseases are primarily antibody‐mediated)
- Tolerization of CD4 + helper T cells = tolerization of helper‐dependent B cell responses (i.e., against protein‐derived antigens)
-Note: a BCR must be expressed for a
B cell to be positively selected (‘tonic’ [baseline] signaling is required from the presence of BCRs)
-low dose antigens (These are usually self antigens (self‐recognition = negative selection))
very low/high doses of antigen may cause tolerance
-The ability of different doses of antigen to induce peripheral tolerance. Both very low and very high doses can induce tolerance.
Moderate doses, in contrast, usually induce an immune response
negative feedback regulation of antibody responses
- The presence of high concentrations of antibodies/immunoglobulins generally suppresses new B cell responses
- IgG antibodies tend to suppress the production of both IgM and IgG
- IgM antibodies tend to suppress only the synthesis of IgM
- Specific antibodies tend to suppress a specific immune response better than nonspecific immunoglobulins
- Suppression is the result of antibodies binding to an inhibitory B cell receptor (i.e., CD32b; aka FcγRIIb)
-Cross‐linkage between a BCR and CD32, an Fc receptor, by antibody and antigen can turn off a B cell by activating a phosphatase that in turn blocks signaling by tyrosine kinase
- The presence of high concentrations of antibodies/immunoglobulins generally suppresses new B cell responses
negative implication of antibody mediated regulation of B cell responses; maternal antibodies
-The presence of maternal antibodies/immunoglobulins in a newborn animal effectively delays the onset of synthesis of new immunoglobulins/antibodies through a negative feedback process. This reduces the efficacy of vaccines in neonates; thus, the rationale for delaying vaccination
negative implication of antibody mediated regulation of B cell responses; myelomas
- Myelomas = cancerous plasma cells
(Greek myelo‐ ‘marrow’ and ‐oma ‘tumor’) - They produce very large quantities of immunoglobulins
- This causes negative feedback inhibition of B cell responses
- Patients become susceptible to infections due to weak
antibody responses
positive implication of antibody mediated regulation of B cell responses; hemolytic disease
- Hemolytic disease in human newborns
- Caused when a mother who lacks the Rhesus (Rh) blood group antigen gives birth to a child that is Rh +
- If nothing is done, at the time of birth there is mixing of blood and
the mother develops Rh‐specific antibodies - If a subsequent child is Rh +, these antibodies will cross the placenta and lyse red blood cells, causing anemia
(sometimes leading to death) - If a mother receives antibodies against Rh just before initial exposure
to Rh + fetal red blood cells at birth, she will be completely prevented
from making Rh‐specific antibodies of her own (and subsequent babies won’t be at risk of developing hemolytic anemia) - Anti‐Rh destroys fetal RBCs before the mother responds, plus, there is negative feedback inhibition of B cell responses